No Data
No Data
Lifecome Biochemistry (002868.SZ): signed a supply agreement for methylene salicylic acid peptide with Solvay Biopharmaceuticals Belgium.
Lifecome Biochemistry (002868.SZ) announced on June 28 that it has signed a supply agreement for methylene salicylic acid peptide with Zoetis Belgium S.A. (referred to as “Zoetis”) for the years 2024 to 2026. The agreement covers the supply of methylene salicylic acid peptide for three years.
Lifecome Biochemistry (002868.SZ): Plans to transfer 100% equity of Wuhan Lifecome to Putan Thermal Energy for 27.3 million yuan.
On June 28th, Gelonhui announced that in order to focus on its main business, strengthen the management of business synergy of its subsidiaries, and further optimize its asset and business structure, Lifecome Biochemistry (002868.SZ) plans to transfer 100% equity of its wholly-owned subsidiary Wuhan Lifecome Bio-technology Co., Ltd. (hereinafter referred to as Wuhan Lifecome) to Fujian Putan Thermal Power Co., Ltd. (hereinafter referred to as Putan Thermal Power) for a transaction price of 27.3 million yuan. After the completion of the transaction, the company will no longer hold equity in Wuhan Lifecome, and Wuhan Lifecome will no longer be included in the company's consolidated financial statements. The transaction does not involve the target company.
Lifecome Biochemistry Names Chairman
Lifecome Biochemistry (SHE:002868) elected Lai Tanping as chairman of the Chinese biopharmaceutical company, according to a Wednesday filing with the Shenzhen Stock Exchange. The company's shares clos
Lukang Biochemical (002868.SZ): A biological preservative produced by microbial fermentation is being developed
Gelonghui, May 16, 丨 Lukang Biochemical (002868.SZ) held a performance briefing on May 15, 2024. Regarding “Please ask about your future plans for food additives,” the company replied that the natamycin series products currently produced by the company are mainly used for food preservation and preservation. Future product plans in the direction of food additives are developing biological preservatives produced using microbial fermentation.
Implementation of Lukang Biochemical (002868.SZ) related supervisors' and senior management holdings reduction plan completed
Lukang Biochemical (002868.SZ) issued an announcement. As of the disclosure date of this announcement, the company's supervisors and executives Feng Zhenwu,...
Lukang Biochemical (002868.SZ): Net loss of 31.3428 million yuan in the first quarter
Gelonghui, April 30, 丨 Lukang Biochemical (002868.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 160 million yuan, up 60.09% year on year; net profit attributable to shareholders of listed companies was 31.3428 million yuan, an increase in year-on-year losses; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - RMB 32.2093 million; and basic earnings per share - 0.2 yuan.
No Data